 | Up a level |
Meier, C; Freiburghaus, K; Bovet, C; Schniering, J; Allanore, Y; Distler, O; Nakas, C; Maurer, B (2020). Serum metabolites as biomarkers in systemic sclerosis-associated interstitial lung disease. Scientific reports, 10(1), p. 21912. Springer Nature 10.1038/s41598-020-78951-6
Bütikofer, Lukas; Varisco, Pierre A; Distler, O; Kowal-Bielecka, O; Allanore, Y; Riemekasten, G; Villiger, P.M.; Adler, S. (2020). ACE inhibitors in SSc patients display a risk factor for scleroderma renal crisis-a EUSTAR analysis. Arthritis research & therapy, 22(1), p. 59. BioMed Central 10.1186/s13075-020-2141-2
Meier, FM; Frommer, KW; Dinser, R; Walker, UA; Czirjak, L; Denton, CP; Allanore, Y; Distler, O; Riemekasten, G; Valentini, G; Müller-Ladner, U; Matucci-Cerinic, M; Guiducci, S; Tyndall, A; Lapadula, G; Iannone, F; Becvar, R; Sierakowsky, S; Kowal-Bielecka, O; Cutolo, M; ... (2012). Update on the profile of the EUSTAR cohort: an analysis of the EULAR Scleroderma Trials and Research group database. Annals of the rheumatic diseases, 71(8), pp. 1355-1360. London: BMJ Publishing Group 10.1136/annrheumdis-2011-200742
